Author

L. Bayer

h-index 4 View on Semantic Scholar

We have 2 of 16 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Jul 2026

Cost-effectiveness of RSVpreF for the prevention of respiratory syncytial virus illness among high-risk adults in Germany.

Expanding the recommendation to include IC or CMC+/IC adults aged 18-59 years could substantially reduce the clinical burden of RSV-LRTI in Germany; including IC 18-59-year-olds would also be cost-saving.

Erin Quinn, M. MacKinnon, Severin Freisberg et al. · Expert Review of Vaccines · 0 citations

Open access Mar 2026

Leveraging Large Language Models to Address Common Vaccination Myths and Misconceptions

It is suggested that current general-purpose LLMs can deliver accurate debunking of widely documented vaccine myths under realistic conditions, but that linguistic complexity and framing-sensitive style may limit accessibility.

Florian Reis, L. Bayer, C. Malerczyk et al. · medRxiv · 0 citations